Russell Investments Group
NUVB icon

Russell Investments Group’s Nuvation Bio NUVB Stock Holding History

Russell Investments Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
265,700
+241,244
+986% +$1.34M ﹤0.01% 2150
2025
Q4 		$219K Buy
24,456
+3,681
+18% +$22.8K ﹤0.01% 2818
2025
Q3 		$76.9K Buy
20,775
+20,671
+19,876% +$56.3K ﹤0.01% 3118
2025
Q2 		$203 Sell
104
-15,791
-99% -$32.9K ﹤0.01% 3789
2025
Q1 		$28K Hold
15,895
– – ﹤0.01% 3042
2024
Q4 		$42.3K Buy
15,895
+15,791
+15,184% +$40.7K ﹤0.01% 2856
2024
Q3 		$238 Sell
104
-89,960
-100% -$274K ﹤0.01% 3622
2024
Q2 		$263K Buy
90,064
+56,485
+168% +$172K ﹤0.01% 2405
2024
Q1 		$122K Sell
33,579
-4,500
-12% -$8.64K ﹤0.01% 2539
2023
Q4 		$57.5K Buy
38,079
+5,526
+17% +$7.11K ﹤0.01% 2625
2023
Q3 		$43.6K Buy
32,553
+6,421
+25% +$10.7K ﹤0.01% 2772
2023
Q2 		$47K Hold
26,132
– – ﹤0.01% 2730
2023
Q1 		$43.4K Buy
+26,132
New +$53K ﹤0.01% 2730

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Russell Investments Group's NUVB Position: Q1 2026 in Review

Russell Investments Group increased its Nuvation Bio (NUVB) stake by 986% in Q1 2026, buying an estimated $1.34M and bringing the position to 265,700 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

Russell Investments Group first reported a position in NUVB in Q1 2023 and has held it in 13 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Russell Investments Group held 265,700 shares of Nuvation Bio worth $1.14M as of Q1 2026.
  • Russell Investments Group bought 241,244 Nuvation Bio shares in Q1 2026, an estimated $1.34M.
  • Nuvation Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2150 holding.
  • Russell Investments Group first reported a position in Nuvation Bio in Q1 2023 and has held it in 13 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.